Skip to main content

Published locations for FDA okays new indication for alirocumab in homozygous FH

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA okays new indication for alirocumab in homozygous FH

User login

  • Reset your password
  • /content/fda-okays-new-indication-alirocumab-homozygous-fh
  • /familypracticenews/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous
  • /hematologynews/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /internalmedicinenews/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab
  • /clinicalendocrinologynews/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab
  • /jcomjournal/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /hematology-oncology/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab
  • /ecardiologynews/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /cardiology/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /endocrinology/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /internalmedicine/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous
  • /familymedicine/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous-fh
  • /emergencymedicine/article/238067/cad-atherosclerosis/fda-okays-new-indication-alirocumab-homozygous